Skip to main content
Dawnrays Pharmaceutical (Holdings) Limited logo

Dawnrays Pharmaceutical (Holdings) Limited — Investor Relations & Filings

Ticker · 2348 HKEX Manufacturing
Open in API
Filings indexed 1,032 across all filing types
Latest filing 2026-04-23 Report Publication Anno…
Country HK Hong Kong
Listing HKEX 2348

About Dawnrays Pharmaceutical (Holdings) Limited

http://www.dawnrays.com

Dawnrays Pharmaceutical (Holdings) Limited is principally engaged in the development, manufacture, and sale of non-patented pharmaceutical medicines. The company specializes in cephalosporin antibiotics and a range of system-specific medicines, including cardiovascular treatments. Founded in December 1995, Dawnrays focuses on developing high-quality drugs designed to reduce patient treatment costs and meet basic market requirements. Its primary market for sales is Mainland China.

Recent filings

Filing Released Lang Actions
NOTIFICATION LETTER AND REQUEST FORM TO NON-REGISTERED HOLDER - NOTICE OF PUBLICATION OF 2025 ANNUAL REPORT, CIRCULAR, NOTICE OF ANNUAL GENERAL MEETING, PROXY FORM AND 2025 ENVIRONMENTAL, SOCIAL AND G
Report Publication Announcement Classification · 1% confidence The document is a notification letter to non-registered shareholders about the "Notice of publication of 2025 Annual Report, Circular... and 2025 Environmental, Social and Governance Report," providing website links and a request form for printed copies. It does not contain the reports themselves or substantive financial data, but merely announces their publication and availability. This fits the definition of a Report Publication Announcement (RPA).
2026-04-23 English
NOTIFICATION LETTER AND REPLY FORM TO REGISTERED SHAREHOLDERS - NOTICE OF PUBLICATION OF 2025 ANNUAL REPORT, CIRCULAR, NOTICE OF ANNUAL GENERAL MEETING, PROXY FORM AND 2025 ENVIRONMENTAL, SOCIAL AND G
Report Publication Announcement Classification · 1% confidence The document is a notification letter to registered shareholders informing them of the publication of the Company’s 2025 Annual Report, Circular (including the AGM notice, proxy form and proposals for general mandates and re-election of directors) and the 2025 ESG Report on its website. It does not contain the full report or AGM materials themselves but merely announces their availability and provides a reply form for delivery preferences. This matches the definition of a Report Publication Announcement (RPA).
2026-04-23 English
2025 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
Environmental & Social Information Classification · 1% confidence The document is a full-length Environmental, Social and Governance (“ESG”) Report for the year ended 31 December 2025. It contains detailed ESG governance structure, reporting framework, scope, materiality assessment, and quantitative KPIs across environmental, social and governance topics. It is not a short announcement but the substantive report itself. This matches the definition of Environmental & Social Information (Code: SR).
2026-04-23 English
Form of proxy for use at the Annual General Meeting of the Company to be held on Friday, 22 May 2026 (or at any adjournment thereof)
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a Form of Proxy for use at the Annual General Meeting, sent to shareholders to appoint proxies and vote on resolutions. It is not the AGM presentation itself nor the full annual report, but rather a solicitation of votes and information statement for the meeting. This falls squarely under Proxy Solicitation & Information Statement (PSI).
2026-04-23 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal Notice of Annual General Meeting setting out resolutions for shareholder approval, proxy appointment details, and meeting logistics. It is sent to shareholders to provide information and solicit votes for the upcoming AGM, which matches the definition of Proxy Solicitation & Information Statement (PSI).
2026-04-23 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES; RE-ELECTION OF DIRECTORS AND NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a shareholder circular (“THIS CIRCULAR IS IMPORTANT…”) providing proposals for general mandates to issue and repurchase shares, re-election of directors, explanatory statements, and a notice of the Annual General Meeting with an accompanying proxy form. It is clearly a proxy solicitation/information statement sent to shareholders to request votes at the AGM, matching the “Proxy Solicitation & Information Statement (PSI)” category.
2026-04-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.